# The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia

> **NCT00209027** · NA · TERMINATED · sponsor: **Emory University** · enrollment: 20 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **OTHER:** fMRI
- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT00209027
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-04
- **Primary completion:** 2010-12
- **Final completion:** 2011-04
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** difficulty with technical aspect of fMRI, resources to complete the study ran out
- **Last updated:** 2013-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209027, "The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00209027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*